HomeVSTM • NASDAQ
add
Verastem Inc
Previous close
$9.78
Day range
$9.66 - $10.24
Year range
$3.46 - $11.25
Market cap
776.18M USD
Avg Volume
2.61M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 11.24M | — |
Operating expense | 50.29M | 35.80% |
Net income | -98.52M | -311.06% |
Net profit margin | -876.34 | — |
Earnings per share | -0.54 | 38.64% |
EBITDA | -40.42M | -9.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 137.71M | 21.68% |
Total assets | 176.85M | 39.94% |
Total liabilities | 192.38M | 104.31% |
Total equity | -15.53M | — |
Shares outstanding | 66.78M | — |
Price to book | -42.52 | — |
Return on assets | -54.56% | — |
Return on capital | -104.55% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -98.52M | -311.06% |
Cash from operations | -36.22M | -52.20% |
Cash from investing | -8.28M | — |
Cash from financing | 17.88M | -66.64% |
Net change in cash | -26.62M | -189.30% |
Free cash flow | -29.46M | -194.57% |
About
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
Founded
2010
Headquarters
Website
Employees
78
